Cefotaxime-induced Stevens-Johnson syndrome

Cefotaxime-induced Stevens-Johnson syndrome

Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are severe cutaneous immune-complex hypersensitivity reactions. Drugs, especially sulfa drugs, antiepileptics, and antibiotics like cephalosporins, are the most common causes. Maculopapular lesions rapidly spread and coalesce, leadi...

Full description

Bibliographic Details
Main Author:	Sandeep Lahiry
Format:	Article
Language:	English
Published:	Manipal College of Medical Sciences, Pokhara 2016-10-01
Series:	Asian Journal of Medical Sciences
Subjects:	stevens-johnson syndrome erythema multiforme toxic epidermal necrolysis cefotaxime
Online Access:	https://www.nepjol.info/index.php/AJMS/article/view/15594

Similar Items

Topical fluroquinolone-induced Stevens-Johnson syndrome: A case report
by: Sandhya Ramachandra, et al.
Published: (2016-01-01)

Epidermal necrolysis (Stevens–Johnson syndrome and toxic epidermal necrolysis): Historical considerations
by: Jean-Claude Roujeau
Published: (2013-12-01)

Investigation of Monnose-Binding Lectin gene Polymorphism in Patients with Erythema Multiforme, Stevens-Johnson Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Syndrome
by: Sevil Toka, et al.
Published: (2012-09-01)

Stevens–Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database
by: Bernardo Sousa-Pinto, et al.
Published: (2018-01-01)

Drug Induced Erythema Multiforme: Two Case Series with Review of Literature
by: Shreyas N. Shah, et al.
Published: (2014-09-01)

Stevens-Johnson syndrome and toxic epidermal necrolysis in children
by: Sudip Das, et al.
Published: (2018-01-01)

Stevens-Johnson syndrome in an adolescent: diagnosis and treatment (clinical case)
by: S.O. Nykytiuk, et al.
Published: (2019-02-01)

Evaluation of patients with erythema exudativum multiforme, Stevens‐Johnson syndrome, and toxic epidermal necrolysis treated at our department during the previous 9‐year period
by: Midori Kawasaki‐Nagano, et al.
Published: (2022-10-01)

Retrospective Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in 88 Chinese Patients
by: Li Wang, et al.
Published: (2017-01-01)

A Retrospective Study: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
by: Yuli Wahyu Rahmawati, et al.
Published: (2016-10-01)

Stevens–Johnson syndrome/toxic epidermal necrolysis overlap syndrome due to oral phenytoin
by: J Harikrishna, et al.
Published: (2021-01-01)

Performance of the SCORTEN in Taiwanese patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
by: Yu-Ling Ho, et al.
Published: (2010-03-01)

Management of stevens-johnson syndrome-toxic epidermal necrolysis: Looking beyond guidelines!
by: Rajesh Kumar, et al.
Published: (2018-01-01)

A case of Stevens-Johnson syndrome treated with oral cyclosporine
by: Victoria Griffith, et al.
Published: (2023-01-01)

Oral Acetazolamide after Boston Keratoprosthesis in Stevens Johnson Syndrome
by: Kumar Radhika, et al.
Published: (2012-04-01)

Fatal Toxic Epidermal Necrolysis Induced by Carbamazepine Treatment in a Patient Who Previously had Carbamazepine-induced Stevens-Johnson Syndrome
by: Li-Yen Huang, et al.
Published: (2007-12-01)

Steven-Johnson Syndrome
by: Pauline Joy F. Santos, et al.
Published: (2017-07-01)

Study of ocular manifestations of Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Arundha Abrol, et al.
Published: (2020-01-01)

A Review of the Systemic Treatment of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
by: Hua-Ching Chang, et al.
Published: (2022-08-01)

Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination
by: Ajay Kumar, et al.
Published: (2011-01-01)

Genitourinary management and follow-up for patients with Stevens-Johnson syndrome/toxic epidermal necrolysis
by: Gina T. Baaklini, et al.
Published: (2023-04-01)

Ophthalmic Aspects of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review
by: Gábor Tóth, et al.
Published: (2023-05-01)

Phenytoin induced Steven–Johnson syndrome and bronchiolitis obliterans – case report and review of literature
by: Bibek S. Pannu, et al.
Published: (2016-01-01)

A retrospective analysis of infections and antibiotic treatment in patients with Stevens–Johnson syndrome and toxic epidermal necrolysis
by: Min Diao, et al.
Published: (2020-01-01)

Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis over a period of 10 years
by: Abarna Devi Sanmarkan, et al.
Published: (2011-01-01)

A pediatric case of Stevens-Johnson syndrome/toxic epidermal necrolysis with rapid response to intravenous cyclosporine
by: Ali Alajmi, MD, et al.
Published: (2020-06-01)

Daunorubicin induced Stevens‐Johnson syndrome: A case report
by: Preeti Shakya, et al.
Published: (2021-07-01)

Syndroma Stevens-Johnson - toxic epidermal necrolysis overlap associated with carbamazepine in patient with secondary epilepsy caused by brain tumor (Glioblastoma multiforme)
by: Vojvodić A., et al.
Published: (2015-01-01)

French referral center management of Stevens–Johnson syndrome/toxic epidermal necrolysis
by: Laurence Valeyrie-Allanore, et al.
Published: (2013-12-01)

Cyclosporine monotherapy in pediatric Stevens–Johnson syndrome and toxic epidermal necrolysis: Preserving sepsis indicators while promoting recovery
by: Simran S Tuli, et al.
Published: (2023-01-01)

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Patients Admitted to Sina Hospital in Hamadan, Iran: A 16-year study
by: Pedram Alirezaei, et al.
Published: (2019-03-01)

Stevens Johnson syndrome and toxic epidermal necrolysis – an Australian analysis of treatment outcomes and mortality
by: Alain Khoi Tran, et al.
Published: (2019-10-01)

Analysis of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Japan from 2000 to 2006
by: Yumiko Yamane, et al.
Published: (2007-01-01)

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash
by: Eda Ataseven, et al.
Published: (2016-05-01)

Stevens-Johnson syndrome in a child: case report and minireview
by: Iryna CHORNOMYDZ, et al.
Published: (2020-06-01)

The Profiles of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) Patients in Tertiary Hospital
by: William Andrew Isaac, et al.
Published: (2021-07-01)

Diagnosis and management of drug-induced stevens-johnson syndrome: Report of two cases
by: M Venkateshwarlu, et al.
Published: (2011-01-01)

DRUG-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
by: Dalia Dop, et al.
Published: (2016-12-01)

Stevens-Johnson syndrome associated with antimicrobial agent
by: Ivo Cavalcanti Pita Neto, et al.
Published: (2008-01-01)

Acute skin failure due to toxic epidermal necrolysis - Allopurinol induced
by: B S Gill, et al.
Published: (2016-01-01)